Order the NovaSeq X Series
Advanced chemistry, optics, and informatics combine to deliver exceptional speed and data quality, outstanding throughput and scalability.
This sequencing research panel targets genetic variants associated with cardiac arrhythmias and cardiomyopathies. It assesses 92 heart function-related genes.
This research panel provides a quick, accurate, and cost-effective way to study genetic variants associated with cardiac arrhythmias and cardiomyopathies. It assesses 92 genes known to harbor variants affecting heart functioning. It was designed based on extensive curation of peer-reviewed literature, disease research databases, and consultation with key opinion leaders.
AmpliSeq for Illumina Community Panels are made-to-order. We provide the designs for your convenience; however, they do not have associated performance metrics. For predesigned and tested content, view AmpliSeq for Illumina Ready-to-Use Panels.
AmpliSeq for Illumina Community Panels contain content selected and designed with input from leading disease researchers. You can order this community panel as is, or customize the panel to meet your needs, using DesignStudio software to add or remove genes and amplicons.
Input quantity | 1–100 ng; recommended 10 ng per pool |
---|---|
Method | Amplicon sequencing |
Nucleic acid type | DNA |
Number of amplicons | 2198 total. 2 pools. (Pool 1: 1103 amplicons. Pool 2: 1095 amplicons). |
Species category | Human |
Technology | Sequencing |
In addition to the community panel, you will also need an AmpliSeq Library PLUS kit and index adapters.
AmpliSeq™ Cardiac Arrhythmias and Cardiomyopathy Research Panel for Illumina®
20020495
Custom assay supporting 750 or 3000 samples with < 4999 amplicons. Purchase Library PLUS and index adapters separately.
List Price:
Discounts:
Showing of
Product
Qty
Unit Price
Product
Catalog ID
Quantity
Unit price
Reach out for information about our products and services, or get answers to questions about our technology.
Your email address is never shared with third parties.